We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.35
Bid: 3.30
Ask: 3.40
Change: 0.00 (0.00%)
Spread: 0.10 (3.03%)
Open: 3.35
High: 3.35
Low: 3.35
Prev. Close: 3.35
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

19 Oct 2021 12:23

RNS Number : 5525P
ValiRx PLC
19 October 2021
 

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

ValiRx PLC

 

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

Adam Hargreaves

City and country of registered office (if applicable)

Cheshire, UK

4. Full name of shareholder(s) (if different from 3.) v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached vi:

18/10/2021

6. Date on which issuer notified (DD/MM/YYYY):

19/10/2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

3.94%

4.21%

8.15%

5,302,452

Position of previous notification (if

applicable)

3.89%

3.78%

7.67%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GB00BLH13C52

2,562,580

3.94%

GB00BLH13C52

2,739,872

4.21%

SUBTOTAL 8. A

5,302,452

8.15%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

X

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Hargreaves Lansdown (Direct Holding)

3.94%

8.15%

PathCelerate Ltd. (Indirect Holding)

4.21%

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

 

Place of completion

London, UK

Date of completion

19/10/2021

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUKUARAAURAAA
Date   Source Headline
6th May 20204:23 pmRNSPosting of Circular and Notice of General Meeting
6th May 20209:05 amRNSHolding(s) in Company
4th May 20203:00 pmRNSBroker Option - Fully Subscribed
4th May 20208:27 amRNSHolding(s) in Company
4th May 20208:24 amRNSHolding(s) in Company
4th May 20207:00 amRNSConditional Fundraise of £1.2 million
1st May 20201:34 pmRNSShare Price Movement
1st May 20209:21 amRNSHolding(s) in Company
1st May 20208:16 amRNSMaterial Transfer Agreement
1st May 20207:00 amRNSProposed appointment of Director
30th Apr 20208:00 amRNSHolding(s) in Company
30th Apr 20207:00 amRNSChange of Management Team
29th Apr 20205:42 pmRNSStatement re social media reports
24th Apr 20207:00 amRNSHolding(s) in Company
23rd Apr 202011:04 amRNSHolding(s) in Company
16th Apr 20202:05 pmRNSSecond Price Monitoring Extn
16th Apr 20202:00 pmRNSPrice Monitoring Extension
14th Apr 202012:41 pmRNSResult of General Meeting & Directorate Change
14th Apr 202010:08 amRNSChange of Director
9th Apr 20202:39 pmRNSChange of Arrangements for General Meeting
1st Apr 202011:59 amRNSResult of General Meeting
1st Apr 20207:00 amRNSConditional Placing
30th Mar 20207:00 amRNSUpdate
25th Mar 20209:44 amRNSGeneral Meeting - Adjournment
16th Mar 20207:00 amRNSPosting of Circular & Notice of General Meeting
10th Mar 20207:00 amRNSPosting of Circular & Notice of General Meeting
4th Mar 20203:28 pmRNSShareholder Requisition Notice
17th Feb 20202:05 pmRNSSecond Price Monitoring Extn
17th Feb 20202:00 pmRNSPrice Monitoring Extension
17th Feb 202012:07 pmRNSResult of General Meeting & working capital update
12th Feb 20207:00 amRNSChange of Venue for General Meeting-17 Feb 2020
30th Jan 20202:00 pmRNSPosting of Circular & Notice of General Meeting
14th Jan 20207:00 amRNSUpdate - ValiSeek
6th Jan 20207:00 amRNSPlacing, Issue of Warrant & Appointment of Broker
16th Dec 20199:05 amRNSSecond Price Monitoring Extn
16th Dec 20199:00 amRNSPrice Monitoring Extension
16th Dec 20197:00 amRNSVAL201 Update
28th Nov 20197:00 amRNSUS Patent Grant re VAL201 & Metastatic Cancer
13th Nov 201911:33 amRNSHolding(s) in Company
13th Nov 20197:00 amRNSAppointment of Joint Broker
11th Nov 20193:30 pmRNSHolding(s) in Company
21st Oct 201911:47 amRNSPassing of Non-Executive Chairman
14th Oct 20191:23 pmRNSPlacing & Issue of Equity
9th Oct 20194:35 pmRNSPrice Monitoring Extension
26th Sep 20197:00 amRNSHalf-year Report
24th Sep 20197:00 amRNSCompany Update
10th Sep 20195:15 pmRNSHolding(s) in Company
10th Sep 20197:00 amRNSVAL201 Update
6th Aug 20197:00 amRNSCompany Update & Change of Adviser
1st Aug 20197:00 amRNSNew European patent allowance for VAL301

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.